Liftstream is an executive search recruitment company in the life sciences sector
Merck announces collaboration with Advaxis
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Advaxis, ADXS-PSA, Amsterdam Biotech, AstraZeneca, Cancer immunotherapy, clinical studies, Daniel O'Connor, David Mauro, Executive Director Oncology, Flanders Biotech, immunotherapy, MedImmune, Merck & Co, Orphan Drug, PD-1, pembrolizumab
Leave a comment
Celgene and BMS team up for cancer immunotherapy development
Authored by James Sheppard
Vaccibody successfully completes 35m NOK financing round
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Artic Securitites, cancer, Cancer immunotherapy, clinical studies, Datum and Partners, financing round, HPV 16, immunotherapy, malignancies caused by Human Papilloma Virus 16 (HPV16)., Medicon Valley, new share, Norway, Norwegian Cancer Society, oncology, Oslo Cluster, public markets, Vaccibody, VB1016
Leave a comment
Amal Therapeutics raises seed funding for cancer immunotherapy
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Amal Therapeutics, bioValley, BIVF, Boehringer Ingelheim, Cancer immunotherapy, Dr Knut Elbers, High-Tech Grunderfonds, HTGF, Madiha Derouazi, multi-epitopic cellular immune response targeting cancer cells, oncology, University of Geneva
Leave a comment